Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1111 AL 1125

Solving the mystery of the diabetes-dementia connection: new clues--but far from "case closed"

Hugenschmidt C, Williamson JD.

J Diabetes Complications. 2014 Jan-Feb;28(1):8-9. doi: 10.1016/j.jdiacomp.2013.09.012. Epub 2013 Oct 5.

Novel lipid signaling pathways in Alzheimer's disease pathogenesis

Giannopoulos PF, Joshi YB, Praticò D.

Biochem Pharmacol. 2014 Apr 15;88(4):560-4. doi: 10.1016/j.bcp.2013.11.005. Epub 2013 Nov 21.

MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy

Xu T, Li L, Huang C, Li X, Peng Y, Li J.

Expert Opin Ther Targets. 2014 Feb;18(2):153-8. doi: 10.1517/14728222.2014.855201. Epub 2013 Nov 27.

The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease

Zhang B, Xu Y, Zhu B, Kantarci K.

CNS Neurosci Ther. 2014 Jan;20(1):3-9. doi: 10.1111/cns.12166. Epub 2013 Dec 12.

On the relation among mood, apathy, and anosognosia in Alzheimer's disease

Mograbi DC, Morris RG.

J Int Neuropsychol Soc. 2014 Jan;20(1):2-7. doi: 10.1017/S1355617713001276. Epub 2013 Dec 13.

Is there a link between gynecologic surgeries and Alzheimer disease?

Rocca WA, Henderson VW.

Neurology. 2014 Jan 21;82(3):196-7. doi: 10.1212/WNL.0000000000000043. Epub 2013 Dec 11.

TREM2 and the neuroimmunology of Alzheimer's disease

Hickman SE, El Khoury J.

Biochem Pharmacol. 2014 Apr 15;88(4):495-8. doi: 10.1016/j.bcp.2013.11.021. Epub 2013 Dec 16.

Matched and mismatched appraisals of the effectiveness of communication strategies by family caregivers of persons with Alzheimer's disease

Savundranayagam MY, Orange JB.

Int J Lang Commun Disord. 2014 Jan-Feb;49(1):49-59. doi: 10.1111/1460-6984.12043. Epub 2013 Oct 24.

Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies

Gandy S.

Biol Psychiatry. 2014 Apr 1;75(7):553-7. doi: 10.1016/j.biopsych.2013.11.019. Epub 2013 Nov 28.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI.

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22.

Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS)

Seppälä TT, Louhija UM, Appelberg B, Herukka SK, Juva K.

Am J Geriatr Psychiatry. 2014 Sep;22(9):908-16. doi: 10.1016/j.jagp.2012.08.020. Epub 2013 Apr 15.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.

Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

Fiolaki A, Tsamis KI, Milionis HJ, Kyritsis AP, Kosmidou M, Giannopoulos S.

Int J Neurosci. 2014 Jan;124(1):1-11. doi: 10.3109/00207454.2013.821988. Epub 2013 Aug 6.

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H.

Alzheimers Dement. 2014 May;10(3):381-92. doi: 10.1016/j.jalz.2013.04.506. Epub 2013 Jul 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias